Efficacy and Safety of Non Invasive Vagal Stimulation to Prevent Chemotherapy-induced Nausea
Status:
Not yet recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
Despite pharmaceutical innovations, chemotherapy induced nausea is frequent and largely
participating to alter our patients quality of life.
Non invasive vagal stimulation is approved in other health issues, for example in headache or
gastroparesis, with a reported benefit on nausea.
This study aims to analyse if a non invasive vagal stimulation could better prevent
chemotherapy induced nausea, in addition to standard treatment, in breast cancer patients
treated with cyclophosphamide and anthracycline.